||Her Majesty's Government (1) what assessment they have made of the potential impact
of not reaching agreement with the EU by April 2019 on the supply of the radioisotope
molybdenum-99 used to produce technetium-99m which is required for over 80 per cent
of diagnostic medicine procedures in the UK; (2) what assessment they have made of
the potential impact of delays or disruption to the supply of diagnostic medicine
procedures that may result; and (3) what contingency plans they have put in place
to mitigate such delays or disruption to that supply after Brexit.